Pharmaceutical compositions and methods for use
US6432954B1 · kind B1 · utility
8Cited by
6References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2000 |
| Grant date | Aug 13, 2002 |
| Priority date | — |
| Expiry date | Jul 14, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are 2,3-diacyltartaric acid salts of nicotinic compounds, and particularly, nicotinic compounds that are characterized as aryl substituted amines (e.g., aryl substituted olefinic amines).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.